XENCOR, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 23.03 USD | +2.54% |
|
+2.45% | +8.48% |
| 15/05 | Transcript : Xencor, Inc. Presents at Bank of America Health Care Conference 2024, May-15-2024 01:40 PM | |
| 10/05 | Wedbush Adjusts Xencor's Price Target to $36 From $34, Keeps Outperform Rating | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| XENCOR, INC. | Bio Therapeutic Drugs | +2.54% | +2.45% | +8.48% | -13.13% | -32.80% | 138.49Cr |  | | |
Technical Rankings Surperformance
- Stock Market
- Equities
- XNCR Stock
- Charts Xencor, Inc.
- Comparison Chart
